Esketamine is approved in Europe for treating resistant major depressive disorder Read More > December 20, 2019
From Egoism to Ecoism: Psychedelics Increase Nature Relatedness in a State-Mediated and Context-Dependent Manner. Read More > December 16, 2019
The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: A systematic review. Read More > December 14, 2019
4-MeO-PCP and 3-MeO-PCMo, new dissociative drugs, produce rewarding and reinforcing effects through activation of mesolimbic dopamine pathway and alteration of accumbal CREB, deltaFosB, and BDNF levels Read More > December 11, 2019
Neuropharmacological modulation of the aberrant bodily self through psychedelics Read More > December 6, 2019
Therapeutic use of serotoninergic hallucinogens: A review of the evidence and of the biological and psychological mechanisms. Read More > December 3, 2019
Embedding existential psychology within psychedelic science: reduced death anxiety as a mediator of the therapeutic effects of psychedelics. Read More > November 29, 2019
Psychedelic studies on depression recruiting subjects in the Netherlands Read More > November 25, 2019
Microdosing psychedelics: Motivations, subjective effects and harm reduction. Read More > November 25, 2019
